CURLF

Curaleaf Holdings

As regulated cannabis markets mature across the U.S., operators are increasingly focused on optimizing retail footprints rather than simply chasing scale. Strategic relocations, upgraded store formats, and enhanced digital ordering capabilities are becoming key differentiators, particularly in established medical markets where patient experience and convenience can directly influence market share.Shares of Curaleaf Holdings, Inc. (OTCQX: CURLF) (TSX: CURA) are moving higher Friday morning in the U.S. after the company announced the opening of a new, expanded dispensary location in Erie, ...

As regulated cannabis markets mature across the U.S., operators are increasingly focused on optimizing retail footprints rather than simply chasing scale. Strategic relocations, upgraded store formats, and enhanced digital ordering capabilities are becoming key differentiators, particularly in established medical markets where patient experience and convenience can directly influence market share.Shares of Curaleaf Holdings, Inc. (OTCQX: CURLF) (TSX: CURA) are moving higher Friday morning in the U.S. after the company announced the opening of a new, expanded dispensary location in Erie, ...

As regulated cannabis markets mature across the U.S., operators are increasingly focused on optimizing retail footprints rather than simply chasing scale. Strategic relocations, upgraded store formats, and enhanced digital ordering capabilities are becoming key differentiators, particularly in established medical markets where patient experience and convenience can directly influence market share.Shares of Curaleaf Holdings, Inc. (OTCQX: CURLF) (TSX: CURA) are moving higher Friday morning in the U.S. after the company announced the opening of a new, expanded dispensary location in Erie, ...

Trump's executive order to move marijuana to Schedule III could reshape cannabis regulation and taxes, lifting sentiment around cannabis stocks.

Tilray's slump deepens as a tighter U.S. hemp rule and a reverse split stir uncertainty despite gains in global cannabis sales.

The development comes close on the heels of President Donald Trump highlighting the potential benefits of cannabidiol in senior healthcare.

CRLBF's move into Germany opens a new growth path as it navigates U.S. pricing pressure and rising competition in its core market.

Canopy Growth's narrower loss, rising Canadian sales and improving margins signal progress in its turnaround, even as competition and global headwinds persist.

TLRY expands its global medical cannabis footprint with key launches and approvals across Panama, Germany, Italy and Australia.